Atlas Trials

The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization.

Clinical trial NCT03696953 · UNKNOWN

Trial details

NCT number
NCT03696953
Sponsor
Marquette University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Group B Streptococcus Carrier in ChildbirthGastrointestinal Symptoms
Start date
2019-02-01
Primary completion
2022-09-30
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.